| Name | Title | Contact Details |
|---|
NNE Pharmaplan is the world's leading engineering and consultancy company focused entirely on the pharma and biotech industries. We employ more than 1500 people world-wide and offer global reach and local knowledge along with our all-encompassing list of
Meridian Health Plan is the largest Medicaid HMO in the State of Michigan, providing health care to over 290,000 Medicaid enrollees through a contract with the Michigan Department of Community Health (MDCH). MHP is a physician-owned, physician-managed Medicaid health plan. Its corporate headquarters are located in Detroit, Michigan. Currently, MHP operates in 67 counties. Meridian Health Plan's Michigan Medicaid HMO received an Excellent Accreditation rating from the National Committee for Quality Assurance (NCQA). Excellent is the highest possible Accreditation status from NCQA. To continuously improve the quality of care in a low resource environment
Cedar provides a smarter way for hospitals, health systems and medical groups to manage the patient payment ecosystem. Our platform delivers modern intelligence to alleviate collections challenges, dramatically improve billing operations and ensure a personalized billing experience for patients. Most revenue cycle solutions today look at only one or two transactional aspects of patient payments. We believe that the focus instead should be on improving the overall experience of patient billing and engagement. Together with the leading medical groups and hospitals across the country, we are elevating the patient payment experience.
Toronto-based digital health firm BlueDot, has developed a first-of-its-kind, global early warning technology for infectious diseases. Using artificial and human intelligence, BlueDot`s outbreak risk platform tracks over 150 infectious diseases globally in 65 languages, around the clock and anticipates their spread and impact. They empower national and international health agencies, hospitals, and businesses to better anticipate, and respond to, emerging threats.
Histogenics is a regenerative medicine company focused on developing and commercializing products in the musculoskeletal segment of the marketplace. Histogenics` regenerative medicine platform combines expertise in cell processing, scaffolding, tissue engineering, bioadhesives and growth factors to provide solutions that can be utilized individually or in concert to treat musculoskeletal-related conditions. Histogenics` first investigational product candidate, NeoCart®, leverages its platform to provide an innovative treatment in the orthopedic space, specifically cartilage damage in the knee.